Skip to main content
SpringerLink
Log in

Growth factors in bladder cancer

  • Published:
World Journal of Urology Aims and scope

Summary

This article is an overview of peptide growth factors, their receptors, and signal-transduction pathways that play a role in bladder cancer. Included in this overview are epidermal growth factor receptor and its ligands, erbB2, fibroblast growth factors, insulin-like growth factor, the transferrin receptor, and transforming growth factor-β. The use of growth factors or growth factor receptors for diagnostic and therapeutic interventions is also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allen LE, Mahrer PA (1993) Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line. J Cell Physiol 155:368–375

    Google Scholar 

  2. Assoian RK, Frolik CA, Roberts AB, Miller DM, Sporn M (1984) Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblasts. Cell 36:35–41

    Google Scholar 

  3. Baird A, Klagsbrun M (1991) The fibroblast growth factor family. An overview. Ann NY Acad Sci 638:3–9

    Google Scholar 

  4. Bamias A, Keane P, Krausz T, Williams G, Epenetos AA (1991) Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma. Cancer Res 51:724–738

    Google Scholar 

  5. Barritault D, Groux-Muscatelli B, Caruelle D, Voisin M-C, Chopin D, Palcy S, Caruelle J-P (1991) aFGF increases with malignancy in human chondrosarcoma and bladder cancer. Ann NY Acad Sci 638:387–393

    Google Scholar 

  6. Basar I, Ayhan A, Bircan K, Ergen A, Tasar C (1991) Transferrin receptor activity as a marker in transitional cell carcinoma of the bladder. Br J Urol 67:165–168

    Google Scholar 

  7. Baskin G, Schenker S, Frosto T, Henderson G (1991) Transforming growth factor-β inhibits epidermal growth factor receptor endocytosis and down-regulation in cultured fetal rat hepatocytes. J Biol Chem 266:13238–13242

    Google Scholar 

  8. Berger MS, Greenfield C, Gullick WJ, Haley J, Downward J, Neal DE, Harris AL, Waterfield MD (1987) Evaluation of epidermal growth factor receptors in bladder tumours. Br J Urol 56:533–537

    Google Scholar 

  9. Blay J, Brown KD (1985) Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J Cell Physiol 124:107–112

    Google Scholar 

  10. Bollag G, McCormick F (1991) Regulators and effectors of ras proteins. Annu Rev Cell Biol 7:601–632

    Google Scholar 

  11. Brachman R, Lindquist PB, Nagashima M, Kohr W, Lipari T, Napier M, Derynck R (1989) Transmembrane TGF-α precursors activate the EGF-TGF-α receptors. Cell 56:691–700

    Google Scholar 

  12. Budillon A, Tagliaferri P, Caraglia M, Torrisi MR, Normanno N, Iacobelli S, Palmieri G, Stoppelli MP, Frati L, Bianco AR (1991) Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermoid cancer cells. Cancer Res 51:1294–1299

    Google Scholar 

  13. Carpenter G (1987) Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 56:881–914

    Article  CAS  PubMed  Google Scholar 

  14. Carpenter G (1992) Receptor tyrosine kinase substrates: src homology domains and signal transduction. FASEB J 6:3283–3289

    Google Scholar 

  15. Carpenter G, Cohen S (1976) 125-I labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol 71:159–171

    Google Scholar 

  16. Chen P, Gupta K, Wells A (1994) Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol 124:547–555

    Google Scholar 

  17. Chen P, Xie H, Sekar C, Gupta K, Wells A (1994) Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 127:847–857

    Article  CAS  PubMed  Google Scholar 

  18. Chodak GW, Scheiner CJ, Zetter BW (1981) Urine from patients with transitional cell carcinoma stimulates migration of capillary endothelial cells. N Engl J Med 305:869–874

    CAS  PubMed  Google Scholar 

  19. Chodak GW, Hospelhorn V, Judge SM, Mayforth R, Koeppen H, Sassa J (1988) Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res 48:2083–2089

    Google Scholar 

  20. Chopin DP, Caruelle J-P, Colombel M, Palcy S, Ravery V, Caruelle D, Abbout CC, Barritault D (1991) Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in the urine. J Urol 150:1126–1130

    Google Scholar 

  21. Cilento BG, Freeman MR, Schneck F, Retik AB, Atala A (1994) Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J Urol 152:665–670

    Google Scholar 

  22. Clemmons DR, Jones JI, Busby WH, Wright G (1993) Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann NY Acad Sci 692:10–21

    Google Scholar 

  23. Coombs LM, Pigott DA, Sweenney E, Proctor AJ, Eydmann ME, Parkinson C, Knowles MA (1991) Amplification and over-expression of c-erb-B2 in transitional cell carcinoma of the urinary bladder. Br J Cancer 63:601–608

    Google Scholar 

  24. Coombs LM, Pigott DA, Eydmann ME, Proctor AJ, Knowles MA (1993) Reduced expression of TGFβ is associated with advanced disease in transitional cell carcinoma. Br J Cancer 67:578–584

    Google Scholar 

  25. Dailey GE, Kraus JW, Orth DN (1978) Homologous radioimmunoassay for human epidermal growth factor (urogastrone). J Clin Endocrinol Metab 46:929–936

    Google Scholar 

  26. Damjanov I, Mildner B, Knowles BB (1986) Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues. Lab Invest 55:588–592

    Google Scholar 

  27. Decker SJ (1990) Epidermal growth factor and transforming growth factor-alpha induce differential processing of the epidermal growth factor receptor. Biochem Biophys Res Commun 166:615–621

    Google Scholar 

  28. Decker SJ (1990) Epidermal growth factor-induced truncation of the epidermal growth factor receptor. J Biol Chem 264:17641–17644

    Google Scholar 

  29. Derynck R (1986) Transforming growth factor-α: structure and biological activities. J Cell Biochem 32:293–304

    Google Scholar 

  30. Derynck R (1988) Transforming growth factor-α. Cell 54:593–595

    Google Scholar 

  31. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH (1987) Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47:707–712

    CAS  PubMed  Google Scholar 

  32. Donato NJ, Gallick GE, Steck PA, Rosenblum MG (1989) Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in tumor cells. J Biol Chem 264:20474–20481

    Google Scholar 

  33. Dougall WC, Qian Y, Peterson NC, Miller MJ, Samanta A, Greene MI (1994) The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 9:2109–2123

    Google Scholar 

  34. Engstrom WM (1986) Differential effects of epidermal growth factor (EGF) on cell locomotion and cell proliferation in a cloned human embryonal carcinoma-derived cell line in vitro. J Cell Sci 86:47–55

    Google Scholar 

  35. Fantl WJ, Johnson DE, Williams LT (1993) Signalling by receptor tyrosine kinases. Annu Rev Biochem 62:453–481

    Google Scholar 

  36. Gibbs JB, Oliff A (1994) Pharmaceutical research in molecular oncology. Cell 79:193–198

    Google Scholar 

  37. Goldenberg A, Masui H, Divgi C, Kanrath H, Pentlow K, Mendelsohn J (1989) Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody. J Natl Cancer Inst 81:1616–1625

    Google Scholar 

  38. Gospodarowicz D (1991) Biological activities of fibroblast growth factors. Ann NY Acad Sci 638:1–8

    Google Scholar 

  39. Gronowski AM, Birtics PJ (1993) Evidence for the potentiation of epidermal growth factor receptor tyrosine kinase activity by association with detergent-insoluble cellular cytoskeleton: analysis of intact and carboxy-terminally truncated receptors. Endocrinology 133:2838–2846

    Google Scholar 

  40. Haley JD, Hsuan JJ, Waterfield MD (1989) Analysis of mammalian fibroblast transformation by normal and mutated human EFG receptors. Oncogene 4:273–283

    Google Scholar 

  41. Hamburger AW, Pinnamaneni GD (1991) Increased epidermal growth factor receptor gene expression by γ-interferon in a breast carcinoma cell line. Br J Cancer 64:64–68

    Google Scholar 

  42. Harney JV, Liebert M, Wedemeyer G, Washington R, Stein J, Buchsbaum D, Steplewski Z, Grossman HB (1991) The expression of epidermal growth factor receptor on human bladder cancer: potential use in radioimmunoscintigraphy. J Urol 146:227–231

    Google Scholar 

  43. Harris AL, Fox S, Bicknell R, Leek R, Relf M, LeJeune S, Kaklamanis L (1994) Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer. Cancer 74:1021–1025

    Google Scholar 

  44. Hirata Y, Orth DN (1979) Epidermal growth factor (urogastrone) in human fluids: size heterogeneity. J Clin Endocrinol Metab 48:673–678

    Google Scholar 

  45. Hsuan JJ (1993) Oncogene regulation by growth factors. Anticancer Res 13:2521–2532

    Google Scholar 

  46. Ilrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Liebermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 squamous carcinoma cells. Nature 309:418–425

    CAS  PubMed  Google Scholar 

  47. Ishida T, Tsujisaki M, Hanzawa Y, Hirakawa T, Hinoda Y, Imai K, Yachi A (1994) Significance of erb-B2 gene product as a target molecule for cancer therapy. Scand J Immunol 39:459–466

    Google Scholar 

  48. Ishitoya J, Toriyama M, Oguchi N, Kitamure K, Ohschima M, Asano K, Yamamoto T (1989) Gene amplification and over-expression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 59:559–562

    Google Scholar 

  49. Iwamure M, Ishibe M, Sluss PM, Cockett ATK (1993) Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines. Urol Res 21:27–32

    Google Scholar 

  50. Jaye M, Schlessinger J, Dionne CA (1992) Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1135:185–199

    Google Scholar 

  51. Kan M, Wang F, Xu J, Crabb JW, Hou J, McKeehan WL (1993) An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259:1918–1921

    Google Scholar 

  52. Khazaie K, Schirrmacher V, Lichtner RB (1993) EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 12:255–274

    Google Scholar 

  53. Khrebtukova IA, Kwiatkowska K, Gudkova DA, Sorokin AB, Pinaev GP (1991) The role microfilmanets in the capping of epidermal growth factor receptor in A431 cells. Exp Cell Res 194:48–55

    Google Scholar 

  54. Kingsley DM (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133–146

    Google Scholar 

  55. Klagsbrun M, Baird A (1991) A dual receptor system is required for basic fibroblast growth factor activity. Cell 67:229–231

    Article  CAS  PubMed  Google Scholar 

  56. Klemke RL, Yebra M, Bayna EM, Cheresh DA (1994) Receptor tyrosin kinase signaling required for αvβ5-directed cell motility but not adhesion on vitronection. J Cell Biol 127:859–866

    Google Scholar 

  57. Lee S-E, Chow N-H, Chi Y-C, Tzai T-S, Yang W-H, Lin S-N (1994) Expression of c-erb-B2 protein in normal and neoplastic urothelium: lack of advese prognostic effect in human urinary bladder cancer. Anticancer Res 14:1317–1324

    Google Scholar 

  58. Lenis J (1993) Signal transduction via the MAP kinase: proceed at your own RSK. Proc Natl Acad Sci USA 90:5889–5892

    Google Scholar 

  59. LeRoith D, Roberts CT (1993) Insulin-like growth factors. Ann NY Acad Sci 692:1–9

    Google Scholar 

  60. Le Roith D, Kavsan VM, Koval AP, Roberts CT (1993) Phylogeny of the insulin-like growth factors (IGFs) and receptors: a molecular approach. Mol Reprod Dev 35:332–338

    Google Scholar 

  61. Limas C (1993) Proliferative state of the urothelium with benign and atypical changes. Correlation with transferrin and epidermal growth factor receptors and blood group antigens. J Pathol 171:39–47

    Google Scholar 

  62. Lipponen PK (1993) Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancer. Pathobiology 61:178–182

    Google Scholar 

  63. Lipponen P, Eskelinen M (1994) Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis. Br J Cancer 69:1120–1125

    CAS  PubMed  Google Scholar 

  64. Lipponen P, Norlin S, Eskellinen M, Jauhanen K, Terho H, Harju E (1993) Flow cytometry in comparison with mitoxotic index in predicting disease outcome in transitional cell bladder cancer. Int J Cancer 53:423–427

    Google Scholar 

  65. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Allrich A, Skolnik EY, Bar-Sagi D, Schlessinger J (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431–442

    Google Scholar 

  66. Mason IJ (1994) The ins and outs of fibroblast growth factor. Cell 78:547–552

    CAS  PubMed  Google Scholar 

  67. Massague J (1990) The transforming growth factor-β family. Annu Rev Cell Biol 6:597–641

    CAS  PubMed  Google Scholar 

  68. Massague J (1990) Transforming growth factor-α. A model for membrane-anchored growth factors. J Biol Chem 265:21393–21396

    Google Scholar 

  69. Massague J (1992) Receptors for the TGF-β family. Cell 69:1067–1070

    Google Scholar 

  70. Massague J, Pandiella A (1993) Membrane-anchored growth factors. Annu Rev Biochem 62:515–541

    Google Scholar 

  71. Mattila A-L, Pasternack A, Viinikka L, Perheentupa J (1986) Subnormal concentrations of urinary epidermal growth factor in patients with kidney disease. J Clin Endocrinol Metab 62:1180–1183

    Google Scholar 

  72. McClelland A, Kuhn LC, Ruddle FH (1984) The human transferrin receptor gene: genomic organization, and the complete primary structure of the receptor deduced from a cDNA sequence. Cell 39:267–274

    Google Scholar 

  73. Messing EM (1990) Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 50:2530–2537

    Google Scholar 

  74. Messing EM, Hanson P, Ulrich P, Erturk E (1987) Epidermal growth factor-interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol 138:1329–1335

    Google Scholar 

  75. Moriyama M, Akiyama T, Yamamoto T, Kawamoto T, Kato T, Sato K, Watanuki T, Hikage T, Katsuta N, Mori S (1991) Expression of c-erbB-2 gene product in urinary bladder cancer. J Urol 145:423–427

    CAS  PubMed  Google Scholar 

  76. Moscatelli D, Flaumenhaft R, Saksela O (1991) Interaction of basic fibroblast growth factor with extracellular matrix receptors. Ann NY Acad Sci 638:177–181

    Google Scholar 

  77. Neal DE, Mellon K (1992) Epidermal growth factor receptor and bladder cancer: a review. Urol Int 48:365–371

    Google Scholar 

  78. Neal DE, March C, Bennett MK, Abel PD, Hall RR, Sainsbury JRC, Harris AL (1985) Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet I:366–369

    Google Scholar 

  79. Neal DE, Smith K, Fennelly JA, Bennett MK, Hall RR, Harris AL (1989) Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand binding. J Urol 141:517–521

    Google Scholar 

  80. Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619–1625

    Google Scholar 

  81. Neckers LM, Trepel JB (1986) Transferrin receptor expression and the control of cell growth. Cancer Invest 4:461–470

    Google Scholar 

  82. Newman MJ (1993) Transforming growth factor beta and the cell surface in tumor progression. Cancer Metastasis Rev 12:239–254

    Google Scholar 

  83. Nguyen M, Watanabe H, Budson E, Richie JP, Folkman J (1993) Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst 85:241–242

    Google Scholar 

  84. Nicolson GL, Ionoue T, Van Pelt CS, Cavanaugh PG (1990) Differential expression of a Mr 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization. Cancer Res 50:515–520

    Google Scholar 

  85. Normanno N, Ciandiello F, Brandt R, Salomon DS (1994) Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res Treat 29:11–27

    Google Scholar 

  86. Palombella VJ, Yamashiro DJ, Maxfield FR, Decker SU, Vilcek J (1987) Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts. J Biol Chem 262:1950–1954

    Google Scholar 

  87. Pessin JE, Frattali AL (1993) Molecular dynamics of insulin: IGF-I receptor transmembrane signaling. Mol Reprod Dev 35:339–345

    Google Scholar 

  88. Puszatal L, Lewis CE, Lorenzen J, McGee J O'D (1993) Growth factors: regulation of normal and neoplastic growth. J Pathol 169:191–201

    Google Scholar 

  89. Rao JY, Hemstreet GP, Hurst RE, Bonner RB, Jones PL, Min KW, Fradet Y (1993) Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. Proc Natl Acad Sci USA 90:8287–8291

    Google Scholar 

  90. Ravery V, Jouanneau J, Diez SG, Abbou CC, Caruelle JP, Barritault D, Chopin DK (1992) Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma. Urol Res 20:211–241

    CAS  PubMed  Google Scholar 

  91. Sarosdy MF, Hutzler DH, Yee D, VonHoff DD (1993) In vitro sensitivity testing of human bladder cancers and cell lines to TP-40, a hybrid protein with selective targeting and cytotoxicity. J Urol 150:1950–1955

    Google Scholar 

  92. Sato K, Mariyama M, Mori S, Saito M, Watanuki T, Terada K, Okuhara E, Akiyama T, Toyoshima K, Yamamota T, Kato T (1992) An immunohistologic evaluation of C-erb-B2 gene products in patients with urinary bladder carcinoma. Cancer 70:2493–2498

    CAS  PubMed  Google Scholar 

  93. Sauter G, Halye J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ, Waldman F (1994) Epidermal growth factor receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer 57:508–514

    Google Scholar 

  94. Schatten C, Pateisky N, Vavra N, Ehrenbock P, Angelberger P, Sivolapenko G, Epenetos A (1991) Lymphoscintigraphy with I-123 labelled epidermal growth factor. Lancet 337:395–396

    Google Scholar 

  95. Schlessinger J (1993) How receptor tyrosine kinases activate ras. Trends Biol 18:273–275

    Google Scholar 

  96. Schlessinger J, Ullrich A (1992) Growth factor signaling by receptor tyrosine kinases. Neuron 9:383–391

    Google Scholar 

  97. Seymour GJ, Walsh MD, Lavin MF, Strutton G, Gardiner RA (1987) Transferrin receptor expression by human bladder transitional cell carcinomas. Urol Res 15:341–344

    Google Scholar 

  98. Shi E, Kan M, Xu J, Wang F, Hou J, McKeehan W (1993) Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants. Mol Cell Biol 13:3907–3918

    Google Scholar 

  99. Siegall CB (1994) Targeted toxins as anticancer agents. Cancer 74:1006–1012

    Google Scholar 

  100. Smith K, Fennelly JA, Neal DE, Hall RR, Harris AL (1989) Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors. Cancer Res 49:5810–5815

    Google Scholar 

  101. Smith NW, Strutton GM, Walsh MD, Wright GR, Seymour GJ, Lavin MF, Gardiner RA (1990) Transferrin receptor expression in primary superficial human bladder tumors identifies patients who develop recurrences. Br J Urol 65:339–344

    Google Scholar 

  102. Sorkin A, Krolenko S, Kudrjavtceva N, Lazebnick J, Teslenko L, Soderquist AM, Nikolsky N (1991) Recyling of epidermal growth factor-receptor complexes in A431 cells: identification of dual pathways. J Cell Biol 112:55–63

    Google Scholar 

  103. Sporn MB, Roberts AB (1986) Peptide growth factors and inflammation, tissue repair, and cancer. Cancer Res 78:329–332

    Google Scholar 

  104. Stoscheck CM, Carpenter G (1984) Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts. J Cell Biol 98:1048–1051

    Google Scholar 

  105. Sugawa N, Ekstrand AJ, James CD, Collins VP (1990) Identical splicing of aberrant epidermal growth factor receptor transcripts for amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 87:8602–8606

    Google Scholar 

  106. Theodorescu D, Cornil I, Sheehan C, Man MS, Kerbel RS (1991) Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells. Cancer Res 51:4486–4491

    Google Scholar 

  107. Theurer CP, Fitzgerald DJ, Pastan I (1993) A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer. J Urol 149:1626–1632

    Google Scholar 

  108. Todaro GJ, Fryling C, DeLargo JE (1980) Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77:5258–5262

    Google Scholar 

  109. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61:203–212

    CAS  PubMed  Google Scholar 

  110. Velu TJ (1990) Structure, function and transforming potential of the epidermal growth factor receptor. Mol Cell Endocrinol 70:205–216

    Google Scholar 

  111. Villereal ML, Byron KL (1992) Calcium signals in growth factor signal transduction. Rev Physiol Biochem Pharmacol 119:68–121

    Google Scholar 

  112. Vlodavsky I, Bashkin P, Ishai-Michaeli R, Chajek-Shaul T, Bar-Shavit R, Haimovitz-Friedman A, Klagsbrun M, Fuks Z (1991) Sequestration and release of basic fibroblast growth factor. Ann NY Acad Sci 638:207–220

    Google Scholar 

  113. Weinstat-Saslow D, Steeg PA (1994) Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 8:401–407

    Google Scholar 

  114. Westermark B, Magnusson A, Heldin C-H (1982) Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res 8:491–507

    Google Scholar 

  115. Wong ST, Winchell LF, McCune BK, Earp HS, Texido J, Massague J, Herman B, Lee DC (1989) The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell 56:495–506

    Google Scholar 

  116. Wood DP, Fair WR, Changanti RSK (1992) Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer. J Urol 147:274–277

    Google Scholar 

  117. Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Horne CHW, Neal DE (1991) Expression of mutant p53, c-erb-B2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63:967–970

    CAS  PubMed  Google Scholar 

  118. Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamoto T, Taniguichi S, Shibuya M (1988) Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erb-B) in human brain tumors. Mol Cell Biol 8:1816–1820

    Google Scholar 

  119. Yayon A, Klagsbrun M (1990) Autocrine regulation of cell growth and transformation by basic fibroblast growth factor. Cell Metastasis Rev 9:191–202

    Google Scholar 

  120. Yee D, Jackson JG, Kozelsky TW, Figueroa JA (1994) Insulin-like growth factor binding protein expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells. Cell Growth Differ 5:73–77

    Google Scholar 

  121. Zhau HE, Zhang X, Eschenbach AC von, Scorsone K, Babaian RJ, Ro JY, Hung M-C (1990) Amplification and expression of the c-erbB-2/neu proto-oncogene in human bladder cancer. Mol Carcinogenesis 3:254–257

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology and Cell Biology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 110, 77030, Houston, TX, USA

    M. Liebert

Authors
  1. M. Liebert
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported in part by grant U01-CA 56973 from the National Cancer Institute, National Institutes of Health

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liebert, M. Growth factors in bladder cancer. World J Urol 13, 349–355 (1995). https://doi.org/10.1007/BF00191216

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00191216

Keywords

Search

Navigation